Core Viewpoint - Shenzhen Hanno Medical Technology Co., Ltd. has submitted its prospectus for an IPO on the Sci-Tech Innovation Board, aiming to raise approximately 1.062 billion yuan for various projects and working capital [3][18]. Group 1: Fundraising and Investment Plans - Hanno Medical plans to raise 1.062 billion yuan, with allocations including 500 million yuan for the R&D center, 200 million yuan for the production base, 109 million yuan for marketing network construction, and 250 million yuan for working capital [4][20]. - The total investment for the R&D center project is 502.88 million yuan, while the production base project is estimated at 200.66 million yuan [4][20]. Group 2: Financial Performance - In the first half of 2025, Hanno Medical reported revenues of 37.35 million yuan and a net loss of 82.27 million yuan [5][21]. - The company’s revenue for 2022, 2023, and 2024 was 0 yuan, 29.83 million yuan, and 49.31 million yuan respectively, with net losses of 64.79 million yuan, 340 million yuan, and 183 million yuan [5][22]. - The asset-liability ratio for 2025 is projected at 72.36%, up from 31.96% in 2022, indicating increasing financial leverage [7][22]. Group 3: Product Pipeline and Focus - Hanno Medical specializes in high-end innovative medical devices, focusing on Extracorporeal Life Support (ECLS) technology, providing stable and reliable circulatory support and oxygenation products [5][21]. - The company has a product pipeline that includes solutions for Extracorporeal Membrane Oxygenation (ECMO), Extracorporeal Cardiopulmonary Resuscitation (ECPR), and Low-Flow Extracorporeal Circulation Support Systems [6][21]. Group 4: Shareholding Structure - Before the IPO, the major shareholders include Beijing Hanno with 24.85%, LI YIJIANG with 10.36%, and other investors such as Baoxing Yili and Daotong holding 9.69% and 7.51% respectively [8][12]. - Post-IPO, Beijing Hanno's shareholding will decrease to 18.64%, while LI YIJIANG's will drop to 7.77% [12][30].

雷递网 雷建平 12月24日 深圳汉诺医疗科技股份有限公司（简称："汉诺医疗"）日前递交招股书，准备在科创板上市。 | 序号 | 项目名称 | 投资总额 | 拟投入募集 资金 | 备案文号 | 环评批复 | | --- | --- | --- | --- | --- | --- | | 1 | 汉诺医疗研发 | 50.288.75 | 50.288.75 | 2504-440306-04-05- | 深环宝备【2025】 | | | 中心建设项目 | | | 266307 | 209 号 | | 2 | 汉诺医疗生产 | 20.066.14 | 20,066.14 | 2504-440306-04-05- | 深环宝备【2025】 | | | 基地建设项目 | | | 765386 | 210 号 | | 3 | 汉诺医疗营销 网络建设项目 | 10.854.11 | 10.854.11 | 不适用 | 不适用 | | 4 | 补充流动资金 | 25,000.00 | 25,000.00 | 不适用 | 不适用 | | | 合计 | 106,209.00 | 106,209.00 | | | 汉诺医疗计划募资 ...